Study of JNJ-88545223 for Active Psoriatic Arthritis
Part of Bones, joints & muscles, Skin clinical trials.
This study tests an experimental drug called JNJ-88545223 to see if it can reduce joint pain, swelling, and skin plaques in people with active psoriatic arthritis. It may help if you have both joint symptoms and psoriasis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with psoriatic arthritis for at least 3 months.
- You currently have at least 3 swollen and 3 tender joints.
- You have a blood test showing some inflammation (CRP level of 0.1 mg/dL or higher).
- You have active plaque psoriasis (a patch bigger than a quarter-inch) or nail changes from psoriasis.
- You are not pregnant or planning to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug (DDY391) in people with moderate to severe psoriatic arthritis. The goal is to see how well it works and if it is safe, which might help reduce joint pain and skin symptoms.
This study tests an oral investigational pill (CBP-0276) called an oral therapy for psoriatic arthritis. The goal is to see if it reduces joint pain, swelling, and psoriasis symptoms better than a placebo (inactive pill).
This trial tests an experimental drug called FT2109 for people with psoriatic arthritis, a condition that causes joint pain, swelling, and skin psoriasis. The study aims to see if FT2109 can reduce symptoms and improve quality of life.
This trial tests an oral medication, D-2570, for people with active psoriatic arthritis. It aims to see if the drug can reduce joint pain and swelling.
This trial tests an experimental oral medication called TQH3906 for people with active psoriatic arthritis (PsA), a condition that causes joint pain, swelling, and skin psoriasis. The study aims to see if TQH3906 is safe and effective in reducing arthritis symptoms.
This study tests an investigational medicine (HS-20118) for people with moderate-to-severe plaque psoriasis. The goal is to see if the drug can safely and effectively reduce psoriasis symptoms and improve quality of life.
Hear when a new Arthritis, Psoriatic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.